Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Poseida Therapeutics Inc PSTX

Healthcare Biotechnology
Poseida Therapeutics, Inc. is a clinical-stage biopharmaceutical company advancing differentiated cell and gene therapies with the capacity to cure certain cancers and rare diseases. Its pipeline includes allogeneic CAR-T cell therapy product candidates for both solid and liquid tumors, as well as in vivo gene therapy product candidates that address patient populations with high unmet medical... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:PSTX)

Poseida Therapeutics, Inc. Announces Agreement to be Acquired by Roche Holdings, Inc.

PR Newswire 5 hours ago

Poseida Therapeutics Hosts Cell Therapy R&D Day Highlighting Its Innovative Clinical and Preclinical Pipeline

PR Newswire 11 days ago

Poseida Therapeutics to Present at Two Upcoming Investor Conferences

PR Newswire November 11, 2024

Poseida Therapeutics Provides Updates and Financial Results for the Third Quarter of 2024

PR Newswire November 7, 2024

Poseida Therapeutics to Present Clinical and Preclinical Data on Investigational Allogeneic CAR-T Cell Therapies at SITC 2024 and ASH 2024

PR Newswire November 5, 2024

Poseida Therapeutics to Present New Preclinical Data Supporting Non-Viral Gene Editing with P-KLKB1-101 for the Treatment of Hereditary Angioedema

PR Newswire October 24, 2024

Poseida Therapeutics Announces Nomination of New CAR-T Development Candidate Under Collaboration with Roche

PR Newswire October 17, 2024

MaxCyte Appoints Cynthia Collins to its Board of Directors

GlobeNewswire October 15, 2024

Poseida Therapeutics Named to Newsweek's List of the Top 200 America's Most Loved Workplaces for 2024

PR Newswire October 3, 2024
View More News ››

Opinion & Analysis (NDAQ:PSTX)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:PSTX)

Poseida Therapeutics, Inc. (NASDAQ:PSTX): A Promising Biotec

http://beyondspx.com/2024/08/02/poseida-therapeutics-inc-nasdaqpstx-a-promising-biotech-poised-for-growth/
MikeTester - August 3, 2024

Upcoming CAR-T Summit

Stock seems to be up they are presenting a Late Breaking abstract at upcoming CAR-T summit. Anyone know anything else about this one?
askretka - August 30, 2021
View more Bullboard ››

Tenet Fintech Group Inc.

Tenet Fintech Group Inc.

Tenet Fintech Group Inc. is the parent company of a group of innovative financial technology (Fintech) and artificial ...
View More »